The inequitable distribution of vaccines during the COVID-19 pandemic was the final proof of the need for more home-grown ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it has received approval to Start Phase II ...

Expects to Submit Conditional Marketing Approval Application in Europe for Iopofosine I 131 in Refractory (post-BTKi) ...

The US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) from Outlook ...

Colas and colleagues used Nordic registries data with family linkage to study 5,721 offspring: 1,950 in Denmark, 1,416 in Norway, and 2,355 in Sweden. Children had fathers who were exposed to ...

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the ...

The African Medicines Agency (AMA) will be officially launched this week in Mombasa, Kenya, at the 7th Conference of African Medicines Regulatory Authorities (SCOMRA), which gets underway Tuesday, ...

Endeavor BioMedicines ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational benefits to patients with life-threatening diseases, ...

Strategic Implications: Analytical findings reported today underscore ABP-450’s potential to become the first full label therapeutic biosimilar to BOTOX® in the U.S., positioning AEON to address a >$3 ...

Combined transactions will strengthen balance sheet and reduce outstanding debt by more than 90% - - $6 million PIPE financing with potential for over $7 million of additional capital via ...

Miguel Forte, current President of the International Society for Cell & Gene Therapy (ISCT), joins Blue Cell as a Non-Executive Director -- Highly experienced executive with deep scientific expertise, ...